These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3707883)

  • 1. Vaginal hyperplasia--a complication of hormone replacement therapy? Case report.
    Campbell JM
    Br J Obstet Gynaecol; 1986 May; 93(5):514-5. PubMed ID: 3707883
    [No Abstract]   [Full Text] [Related]  

  • 2. Estrogen replacement therapy: current thinking and practice.
    DeFazio J; Speroff L
    Geriatrics; 1985 Nov; 40(11):32-7, 40-3, 47-8. PubMed ID: 4054632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous estrogens: a continuing controversy.
    Malkasian GD
    Geriatrics; 1982 Mar; 37(3):79-81, 85-6, 88. PubMed ID: 7067978
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMAS clinical guide: low-dose vaginal estrogens for postmenopausal vaginal atrophy.
    Rees M; Pérez-López FR; Ceasu I; Depypere H; Erel T; Lambrinoudaki I; Schenck-Gustafsson K; Simoncini T; van der Schouw Y; Tremollieres F;
    Maturitas; 2012 Oct; 73(2):171-4. PubMed ID: 22818886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugated estrogens (Premarin) vaginal cream.
    Med Lett Drugs Ther; 2009 Feb; 51(1306):14-5. PubMed ID: 19229162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vulvovaginal complaints.
    Mehta A; Bachmann G
    Clin Obstet Gynecol; 2008 Sep; 51(3):549-55. PubMed ID: 18677149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravaginal oestrogen and progestin administration: advantages and disadvantages.
    Cicinelli E
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):391-405. PubMed ID: 17981510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.
    Simon JA; Reape KZ; Wininger S; Hait H
    Fertil Steril; 2008 Oct; 90(4):1132-8. PubMed ID: 18053998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Various endocrine aspects of the menopause in their relation with therapy].
    Tropea PF
    Rev Fr Gynecol Obstet; 1968 Jun; 63(6):301-4. PubMed ID: 5711742
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.
    Al-Baghdadi O; Ewies AA
    Climacteric; 2009 Apr; 12(2):91-105. PubMed ID: 19117185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. By the way, doctor. My doctor prescribed a low-dose vaginal estrogen cream, applied twice a week, for atrophic vaginitis. I've heard this dose is so low that it carries no health risk. Do you agree?
    Robb-Nicholson C
    Harv Womens Health Watch; 2007 Nov; 15(3):7. PubMed ID: 18225330
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytohormonal and morphological alterations in cervicovaginal smears of postmenopausal women on hormone replacement therapy.
    Gupta S; Kumar N; Singhal N; Manektala U; Jain S; Sodhani P
    Diagn Cytopathol; 2006 Oct; 34(10):676-81. PubMed ID: 16955474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indications critically evaluated: hormone-domain hot flashes].
    MMW Fortschr Med; 2003 Nov; 145(46):5-8. PubMed ID: 14699822
    [No Abstract]   [Full Text] [Related]  

  • 16. Atrophic vaginitis. Estrogen can help.
    Mayo Clin Health Lett; 2001 Jan; 19(1):6. PubMed ID: 11201532
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of 17beta-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy.
    Cotreau MM; Chennathukuzhi VM; Harris HA; Han L; Dorner AJ; Apseloff G; Varadarajan U; Hatstat E; Zakaria M; Strahs AL; Crabtree JS; Winneker RC; Jelinsky SA
    Maturitas; 2007 Dec; 58(4):366-76. PubMed ID: 17997058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term therapy using depot estrogens in the climacteric syndrome].
    Cupr Z; Druckmüller V; Kucera F
    Zentralbl Gynakol; 1969 Jul; 91(27):873-80. PubMed ID: 5363471
    [No Abstract]   [Full Text] [Related]  

  • 19. Practice observed.
    Gray S
    Menopause Int; 2010 Dec; 16(4):169-70. PubMed ID: 21156855
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness and safety of vaginal suppositories for the treatment of the vaginal atrophy in postmenopausal women: an open, non-controlled clinical trial.
    Costantino D; Guaraldi C
    Eur Rev Med Pharmacol Sci; 2008; 12(6):411-6. PubMed ID: 19146203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.